MVP: Fish & Richardson's Dorothy Whelan
Law360, New York (December 19, 2017, 3:24 PM EST) -- Fish & Richardson PC's Dorothy Whelan notched a number of inter partes review victories earlier this year that invalidated key patents on AbbVie's blockbuster autoimmune disease drug Humira, earning her a...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login